Trait centric view

1. Trait name:	Body weight
   Ontology terms:	VT:0001259, CMO:0000012

   138 genes are associated with this trait, with QTL/association found

   • ACSF3: Acyl-CoA synthetase family member 3
     evidenced by: QTL:256088; QTL:256089;
   • ADAMTS12: ADAM metallopeptidase with thrombospondin type 1 motif 12
     evidenced by: QTL:157016; QTL:157029;
   • AMPD1: Adenosine monophosphate deaminase 1
     evidenced by: QTL:12143;
   • ANGPTL3: Angiopoietin-like 3
     evidenced by: QTL:56043; QTL:56044; QTL:56049;
   • ANGPTL4: Angiopoietin like 4
     evidenced by: QTL:237637;
   • APOA2: Apolipoprotein A-II
     evidenced by: QTL:28102;
   • ARHGAP31: Rho GTPase activating protein 31
     evidenced by: QTL:193798;
   • ASAP1: ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
     evidenced by: QTL:224408; QTL:224414;
   • ATM: Ataxia telangiectasia mutated
     evidenced by: QTL:31600;
   • BMP7: Bone morphogenetic protein 7
     evidenced by: QTL:65348; QTL:65349;
   • BMP8B: Bone morphogenetic protein 8b
     evidenced by: QTL:31032; QTL:31034; QTL:31035; QTL:31038;
   • BTG4: B-cell translocation gene 4
     evidenced by: QTL:31598;
   • CAPN1: Calpain 1, (mu/I) large subunit
     evidenced by: QTL:18755; QTL:18756; QTL:18757; QTL:18758; QTL:18759; QTL:20728; QTL:20730; QTL:20734;
   • CAPN2: Calpain 2, (m/II) large subunit
     evidenced by: QTL:13489;
   • CARTPT: CART prepropeptide
     evidenced by: QTL:19981;
   • CAST: Calpastatin
     evidenced by: QTL:18761; QTL:18762; QTL:18763;
   • CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha
     evidenced by: QTL:16144;
   • CEP89: Centrosomal protein 89
     evidenced by: QTL:193757;
   • CHST9: Carbohydrate sulfotransferase 9
     evidenced by: QTL:193770;
   • CHSY3: Chondroitin sulfate synthase 3
     evidenced by: QTL:193758;
   • CIDEC: Cell death-inducing DFFA-like effector c
     evidenced by: QTL:57074;
   • CLCN2: Chloride voltage-gated channel 2
     evidenced by: QTL:255131;
   • CLIC5: Chloride intracellular channel 5
     evidenced by: QTL:193809;
   • CPS1: Carbamoyl-phosphate synthase 1
     evidenced by: QTL:193773; QTL:193777;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:65988;
   • CTPS1: CTP synthase 1
     evidenced by: QTL:193775;
   • CYLC1: Cylicin, basic protein of sperm head cytoskeleton 1
     evidenced by: QTL:56969; QTL:56970;
   • CYLD: CYLD lysine 63 deubiquitinase
     evidenced by: QTL:157027;
   • CYP21: Cytochrome P450, subfamily XXI (steroid 21-hydroxylase)
     evidenced by: QTL:19828;
   • DLK2: Delta-like 2 homolog (Drosophila)
     evidenced by: QTL:31566; QTL:31567;
   • DMD: Dystrophin
     evidenced by: QTL:31611;
   • DNMT3B: DNA (cytosine-5-)-methyltransferase 3 beta
     evidenced by: QTL:30912;
   • DPP6: Dipeptidyl-peptidase 6
     evidenced by: QTL:31727; QTL:31731;
   • EGFR: Epidermal growth factor receptor
     evidenced by: QTL:57070;
   • ERBB3: V-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
     evidenced by: QTL:286852;
   • EXOC6: Exocyst complex component 6
     evidenced by: QTL:157032;
   • FASN: Fatty acid synthase
     evidenced by: QTL:19978;
   • FAT2: FAT atypical cadherin 2
     evidenced by: QTL:157021;
   • FOXA2: Forkhead box A2
     evidenced by: QTL:31146; QTL:31150; QTL:31154;
   • FTO: Fat mass and obesity associated
     evidenced by: QTL:19975; QTL:95234;
   • GAD1: Glutamate decarboxylase 1 (brain, 67kDa)
     evidenced by: QTL:13205; QTL:13209; QTL:13213;
   • GH1: Growth hormone 1
     evidenced by: QTL:122515; QTL:13195;
   • GHR: Growth hormone receptor
     evidenced by: QTL:18448; QTL:18449;
   • GHRH: Growth hormone releasing hormone
     evidenced by: QTL:18740; QTL:18741; QTL:18742; QTL:18743;
   • GHSR: Growth hormone secretagogue receptor
     evidenced by: QTL:18776; QTL:18777; QTL:18780; QTL:18781; QTL:18784; QTL:18785;
   • GTF3C5: General transcription factor IIIC, polypeptide 5, 63kDa
     evidenced by: QTL:31734;
   • HERC3: HECT and RLD domain containing E3 ubiquitin protein ligase 3
     evidenced by: QTL:65969;
   • HGF: Hepatocyte growth factor (hepapoietin A; scatter factor)
     evidenced by: QTL:25223;
   • HMGCLL1: 3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1
     evidenced by: QTL:157030; QTL:157031;
   • HNF4A: Hepatocyte nuclear factor 4, alpha
     evidenced by: QTL:36063; QTL:36067; QTL:36068;
   • IGF1: Insulin-like growth factor 1 (somatomedin C)
     evidenced by: QTL:13104;
   • IGF1R: Insulin-like growth factor 1 receptor
     evidenced by: QTL:57067; QTL:57069; QTL:57072;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:19827; QTL:30844; QTL:30845; QTL:30846; QTL:30847; QTL:30848;
   • INSIG1: Insulin induced gene 1
     evidenced by: QTL:21200;
   • INTS11: Integrator complex subunit 11
     evidenced by: QTL:237612;
   • ITCH: Itchy E3 ubiquitin protein ligase
     evidenced by: QTL:65976;
   • ITGA5: Integrin subunit alpha 5
     evidenced by: QTL:237611;
   • ITPR1: Inositol 1,4,5-trisphosphate receptor type 1
     evidenced by: QTL:193767;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:31733;
   • LEP: Leptin
     evidenced by: QTL:11703; QTL:11704; QTL:122516; QTL:166779; QTL:166780; QTL:166781; QTL:20702; QTL:20741; QTL:20744; QTL:20750;
   • LHX3: LIM homeobox 3
     evidenced by: QTL:56104; QTL:56105; QTL:56106; QTL:56107;
   • LHX4: LIM homeobox 4
     evidenced by: QTL:31601; QTL:32187; QTL:32188;
   • LIG1: Ligase I, DNA, ATP-dependent
     evidenced by: QTL:31602;
   • LOC101904868: CUB and sushi domain-containing protein 1-like
     evidenced by: QTL:31748; QTL:31749; QTL:31750; QTL:31751; QTL:31752;
   • LOC218239: Extracellular matrix protein 2
     evidenced by: QTL:13105;
   • LOC282685: Rhesus-like protein
     evidenced by: QTL:237627;
   • LOC785371: Transcriptional activator GLI3-like
     evidenced by: QTL:25188; QTL:25189;
   • LRP4: LDL receptor related protein 4
     evidenced by: QTL:219986; QTL:220004;
   • LRP6: LDL receptor related protein 6
     evidenced by: QTL:224434;
   • LTBP1: Latent transforming growth factor beta binding protein 1
     evidenced by: QTL:237618;
   • MAP3K5: Mitogen-activated protein kinase kinase kinase 5
     evidenced by: QTL:31595;
   • MC4R: Melanocortin 4 receptor
     evidenced by: QTL:13217; QTL:13218;
   • MDFI: MyoD family inhibitor
     evidenced by: QTL:122237; QTL:122238; QTL:122240; QTL:122241; QTL:122242; QTL:122243;
   • MGC137098: Uncharacterized protein MGC137098
     evidenced by: QTL:31599;
   • MINDY2: MINDY lysine 48 deubiquitinase 2
     evidenced by: QTL:193805;
   • MSI2: Musashi RNA binding protein 2
     evidenced by: QTL:286849;
   • MSTN: Myostatin
     evidenced by: QTL:11631; QTL:11870; QTL:219973; QTL:219985; QTL:219992; QTL:220002; QTL:220005; QTL:24710; QTL:31345;
   • MYF5: Myogenic factor 5
     evidenced by: QTL:31346; QTL:31347; QTL:31348;
   • MYH10: Myosin heavy chain 10
     evidenced by: QTL:193769;
   • NCAPG: Non-SMC condensin I complex, subunit G
     evidenced by: QTL:11394; QTL:4541;
   • NPC1: Niemann-Pick disease, type C1
     evidenced by: QTL:31583; QTL:31586; QTL:31591;
   • NPM1: Nucleophosmin (nucleolar phosphoprotein B23, numatrin)
     evidenced by: QTL:19044; QTL:19045; QTL:19046; QTL:13107; QTL:13110;
   • NPY: Neuropeptide Y
     evidenced by: QTL:18439;
   • NTNG1: Netrin G2
     evidenced by: QTL:31593;
   • NUCB2: Nucleobindin 2
     evidenced by: QTL:13197; QTL:13201;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:37668;
   • PEBP4: Phosphatidylethanolamine binding protein 4
     evidenced by: QTL:224429;
   • PHTF1: Putative homeodomain transcription factor 1
     evidenced by: QTL:237621;
   • PLAG1: Pleiomorphic adenoma gene 1
     evidenced by: QTL:20871; QTL:20872; QTL:56965; QTL:56966;
   • PLCH2: Phospholipase C eta 2
     evidenced by: QTL:157015;
   • PMEL: Premelanosome protein
     evidenced by: QTL:219948; QTL:219974;
   • PPP1R14C: Protein phosphatase 1 regulatory inhibitor subunit 14C
     evidenced by: QTL:193818;
   • PPP2R1A: Protein phosphatase 2, regulatory subunit A, alpha
     evidenced by: QTL:31613;
   • PRDM16: PR domain containing 16
     evidenced by: QTL:11309; QTL:11311;
   • PRLR: Prolactin receptor
     evidenced by: QTL:13129; QTL:20737; QTL:20739;
   • PRNP: Prion protein
     evidenced by: QTL:1391; QTL:1310; QTL:2614;
   • PROP1: PROP paired-like homeobox 1
     evidenced by: QTL:25358; QTL:25366; QTL:25373;
   • PRUNE2: Prune homolog 2 with BCH domain
     evidenced by: QTL:224433;
   • PTPRN: Protein tyrosine phosphatase receptor type N
     evidenced by: QTL:237606;
   • RALGDS: Ral guanine nucleotide dissociation stimulator
     evidenced by: QTL:31735; QTL:31736; QTL:31737; QTL:31738; QTL:31739; QTL:31740; QTL:31741; QTL:31742;
   • RARS1: Arginyl-tRNA synthetase 1
     evidenced by: QTL:237609;
   • RFX6: Regulatory factor X, 6
     evidenced by: QTL:31594;
   • RLF: RLF zinc finger
     evidenced by: QTL:193771;
   • RNF19B: Ring finger protein 19B
     evidenced by: QTL:65965;
   • RNF41: Ring finger protein 41
     evidenced by: QTL:286850;
   • RXRA: Retinoid X receptor, alpha
     evidenced by: QTL:57066; QTL:57068; QTL:57071;
   • SARAF: Store-operated calcium entry associated regulatory factor
     evidenced by: QTL:65987;
   • SASH1: SAM and SH3 domain containing 1
     evidenced by: QTL:193804;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:301162; QTL:301177;
   • SDC1: Syndecan 1
     evidenced by: QTL:12994;
   • SERPINI2: Serpin family I member 2
     evidenced by: QTL:65964;
   • SH2B2: SH2B adaptor protein 2
     evidenced by: QTL:25270; QTL:25279;
   • SIK2: Salt inducible kinase 2
     evidenced by: QTL:65978;
   • SIRT1: Sirtuin 1
     evidenced by: QTL:157276; QTL:25242; QTL:30830; QTL:30835; QTL:30839;
   • SLC38A9: Solute carrier family 38 member 9
     evidenced by: QTL:193781;
   • SLC44A5: Solute carrier family 44, member 5
     evidenced by: QTL:30797;
   • SLC8A1: Solute carrier family 8 (sodium/calcium exchanger), member 1
     evidenced by: QTL:65974;
   • SLCO3A1: Solute carrier organic anion transporter family member 3A1
     evidenced by: QTL:224435;
   • SORCS3: Sortilin-related VPS10 domain containing receptor 3
     evidenced by: QTL:56759;
   • SPACA5: Sperm acrosome associated 5
     evidenced by: QTL:56972; QTL:56973;
   • SREBF1: Sterol regulatory element binding transcription factor 1
     evidenced by: QTL:12999; QTL:13000; QTL:13001; QTL:13002; QTL:13005; QTL:13006; QTL:13008; QTL:13009;
   • STAT6: Signal transducer and activator of transcription 6, interleukin-4 induced
     evidenced by: QTL:20553;
   • TAF7L: TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa
     evidenced by: QTL:56968;
   • TAFA4: TAFA chemokine like family member 4
     evidenced by: QTL:193800;
   • TBC1D5: TBC1 domain family, member 5
     evidenced by: QTL:193803; QTL:237636;
   • TMTC4: Transmembrane O-mannosyltransferase targeting cadherins 4
     evidenced by: QTL:237641;
   • TTC8: Tetratricopeptide repeat domain 8
     evidenced by: QTL:237605;
   • UCP3: Uncoupling protein 3 (mitochondrial, proton carrier)
     evidenced by: QTL:13498;
   • USP32: Ubiquitin specific peptidase 32
     evidenced by: QTL:224421; QTL:224422;
   • UXT: Ubiquitously-expressed, prefoldin-like chaperone
     evidenced by: QTL:56971;
   • VEGFB: Vascular endothelial growth factor B
     evidenced by: QTL:25143; QTL:25144;
   • WNT10B: Wingless-type MMTV integration site family, member 10B
     evidenced by: QTL:30799; QTL:30802;
   • XYLT1: Xylosyltransferase I
     evidenced by: QTL:31747;
   • ZBED6: Zinc finger, BED-type containing 6
     evidenced by: QTL:25229; QTL:25230; QTL:25231; QTL:25232; QTL:25233; QTL:25234; QTL:25235; QTL:25236; QTL:36580; QTL:36586; QTL:36587; QTL:36588; QTL:36596; QTL:36597;
   • ZC3H10: Zinc finger CCCH-type containing 10
     evidenced by: QTL:286851;
   • ZC3H6: Zinc finger CCCH-type containing 6
     evidenced by: QTL:286848;
   • ZNF462: Zinc finger protein 462
     evidenced by: QTL:237628;
   • ZNF75A: Zinc finger protein 75a
     evidenced by: QTL:31608;
   1198 correlations are found involving Body weight
    

2. Trait name:	Metabolic body weight
   Ontology terms:	VT:0001259

   15 genes are associated with this trait, with QTL/association found

   • ABCG2: ATP-binding cassette, sub-family G (WHITE), member 2
     evidenced by: QTL:153969;
   • ATP6V1B2: ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2
     evidenced by: QTL:24265; QTL:24268;
   • CAST: Calpastatin
     evidenced by: QTL:153981; QTL:153986;
   • CCSER1: Family with sequence similarity 190, member A
     evidenced by: QTL:25112;
   • ERCC5: ERCC excision repair 5, endonuclease
     evidenced by: QTL:154064;
   • FAM135B: Family with sequence similarity 135 member B
     evidenced by: QTL:153998;
   • LRRIQ3: Leucine-rich repeats and IQ motif containing 3
     evidenced by: QTL:153961;
   • MAPK15: Mitogen-activated protein kinase 15
     evidenced by: QTL:153995;
   • PCSK6: Proprotein convertase subtilisin/kexin type 6
     evidenced by: QTL:154024;
   • PKD2: Polycystic kidney disease 2 (autosomal dominant)
     evidenced by: QTL:153971; QTL:25114;
   • PPM1K: Protein phosphatase, Mg2+/Mn2+ dependent 1K
     evidenced by: QTL:153967;
   • PTI: Pancreatic trypsin inhibitor
     evidenced by: QTL:24269;
   • SLC45A2: Solute carrier family 45, member 2
     evidenced by: QTL:154022;
   • SMIM19: Small integral membrane protein 19
     evidenced by: QTL:154043;
   • TMEM40: Transmembrane protein 40
     evidenced by: QTL:154027; QTL:154028;
   127 correlations are found involving Metabolic body weight